MPH Health Care AG
XETRA:93M1

Watchlist Manager
MPH Health Care AG Logo
MPH Health Care AG
XETRA:93M1
Watchlist
Price: 22.6 EUR -1.74% Market Closed
Market Cap: 96.8m EUR
Have any thoughts about
MPH Health Care AG?
Write Note

MPH Health Care AG
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MPH Health Care AG
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
MPH Health Care AG
XETRA:93M1
Total Current Assets
€7.1m
CAGR 3-Years
18%
CAGR 5-Years
44%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Total Current Assets
$185.6m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Total Current Assets
€33.1B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Merck KGaA
XETRA:MRK
Total Current Assets
€13.9B
CAGR 3-Years
11%
CAGR 5-Years
1%
CAGR 10-Years
7%
Dermapharm Holding SE
XETRA:DMP
Total Current Assets
€623.1m
CAGR 3-Years
10%
CAGR 5-Years
15%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Total Current Assets
€62.8m
CAGR 3-Years
41%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
No Stocks Found

MPH Health Care AG
Glance View

Market Cap
96.8m EUR
Industry
Pharmaceuticals

MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.

93M1 Intrinsic Value
29.77 EUR
Undervaluation 24%
Intrinsic Value
Price

See Also

What is MPH Health Care AG's Total Current Assets?
Total Current Assets
7.1m EUR

Based on the financial report for Dec 31, 2023, MPH Health Care AG's Total Current Assets amounts to 7.1m EUR.

What is MPH Health Care AG's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
44%

Over the last year, the Total Current Assets growth was 79%. The average annual Total Current Assets growth rates for MPH Health Care AG have been 18% over the past three years , 44% over the past five years .

Back to Top